Sydney Team Shows Mitosis in Human Cardiomyocytes After Infarction Using Live Bypass Tissue

The study collected pre-mortem ventricular biopsies from consenting patients at Royal Prince Alfred Hospital, comparing infarct-adjacent and remote myocardium. Researchers quantified Ki-67 and phospho-histone H3 positive cardiomyocytes, demonstrating elevated mitosis rates after infarction for the first time in humans. This directly extends prior mouse data while bypassing the confounding effects of post-mortem autolysis that limited earlier human studies.

Coverage overlooked the methodological advance of living-tissue sampling, which enables functional assays and molecular profiling impossible with cadaveric samples. The work also highlights a persistent translational gap: even amplified regeneration must overcome scar stiffness and microvascular rarefaction, problems not addressed by mitosis counts alone. Related mouse work on YAP activation and human epicardial progenitor studies suggest combinatorial targets that the Sydney group is now positioned to test.

Next steps require longitudinal imaging cohorts and single-nucleus sequencing of the same biopsies to map the regulatory pathways driving the observed mitosis. Larger multi-center collections will be essential to determine whether regeneration rates differ by age, sex, or comorbidities before any therapeutic amplification trials can be rationally designed.